Ingmar Bruns, Chief Officer of Zentalis Pharmaceuticals ZNTL, has filed 1 purchase and 2 sales on the open market. Over the past 12 months that comes to a net sale of $7,998. The latest trade was on 02/09.

IB

IB

Ingmar Bruns

Chief Medical Officer

Company

Zentalis Pharmaceuticals ZNTL

First filing

24/12/03

Trades

7 trades

Buys / sales

1 / 2

12-month net buying

−$7,998

Last trade

02/09

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Zentalis PharmaceuticalsZNTL	Open-market sale	02/06–02/09	02/10	3,297 sh2 trades	$2.43avg.	$7,998.31	−9.0%
Zentalis PharmaceuticalsZNTL	Open-market buy	25/02/06	25/02/12	20,000 sh	$2.28	$45,600	+120.3%